LSL Pharma Group Inc.
LSL Pharma Group Inc. develops, manufactures, and commercializes sterile pharmaceutical products, cosmetic products, and natural health products in Canada, the United States, and internationally. The company offers dietary supplements and vitamins in the tablet and capsule form; niche sterile ophthalmic products in the form of ointments and drops; and cosmetic, pharmaceutical, and natural health … Read more
LSL Pharma Group Inc. (LSL) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.174x
Based on the latest financial reports, LSL Pharma Group Inc. (LSL) has a cash flow conversion efficiency ratio of -0.174x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-4.42 Million) by net assets (CA$25.38 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
LSL Pharma Group Inc. - Cash Flow Conversion Efficiency Trend (2020–2024)
This chart illustrates how LSL Pharma Group Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
LSL Pharma Group Inc. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of LSL Pharma Group Inc. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
IRCE S.p.A
STU:IRQ
|
0.045x |
|
Yulho Co. Ltd
KQ:072770
|
-0.042x |
|
Ymc Co. Ltd
KQ:155650
|
0.014x |
|
NevGold Corp
OTCQX:NAUFF
|
0.003x |
|
M&F Bancorp Inc
PINK:MFBP
|
0.010x |
|
MAGURO GROUP PUBLIC COMPANY LIMITED
BK:MAGURO
|
-0.149x |
|
SJ Group Co. Ltd
KQ:306040
|
-0.034x |
|
Marvipol S.A.
WAR:MVP
|
-0.061x |
Annual Cash Flow Conversion Efficiency for LSL Pharma Group Inc. (2020–2024)
The table below shows the annual cash flow conversion efficiency of LSL Pharma Group Inc. from 2020 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CA$24.89 Million | CA$-1.65 Million | -0.066x | +91.88% |
| 2023-12-31 | CA$8.65 Million | CA$-7.07 Million | -0.817x | -36.60% |
| 2022-12-31 | CA$5.29 Million | CA$-3.16 Million | -0.598x | -512.51% |
| 2021-12-31 | CA$11.11 Million | CA$-1.08 Million | -0.098x | -519.86% |
| 2020-12-31 | CA$7.48 Million | CA$-117.85K | -0.016x | -- |